These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29644881)

  • 1. Comment on 'Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis'.
    Braun T; Marks D; Thiel C
    Clin Rehabil; 2018 Sep; 32(9):1284-1285. PubMed ID: 29644881
    [No Abstract]   [Full Text] [Related]  

  • 2. Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis.
    McDonnell MN; Rischbieth B; Schammer TT; Seaforth C; Shaw AJ; Phillips AC
    Clin Rehabil; 2018 May; 32(5):607-618. PubMed ID: 28980476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
    Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
    Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)].
    Kamińska I; Zebryk-Stopa A; Pruszewicz A; Dziubalska-Kołaczyk K; Połczyńska-Fiszer M; Pietrala D; Przedpelska-Ober E
    Otolaryngol Pol; 2007; 61(5):713-8. PubMed ID: 18552005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of Lee Silverman Voice Treatment therapy issued interactively through an iPad device: A non-inferiority study.
    Griffin M; Bentley J; Shanks J; Wood C
    J Telemed Telecare; 2018 Apr; 24(3):209-215. PubMed ID: 28147896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Speech therapy of dysarthria in Parkinson's disease].
    Cabrejo L; Auzou P; Ozsancak C; Hannequin D
    Presse Med; 2003 Nov; 32(37 Pt 1):1745-51. PubMed ID: 14663391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
    Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.
    Miles A; Jardine M; Johnston F; de Lisle M; Friary P; Allen J
    J Neurol Sci; 2017 Dec; 383():180-187. PubMed ID: 29246611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
    Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
    Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational Performance and Hand Function in People With Parkinson's Disease After Participation in Lee Silverman Voice Treatment (LSVT) BIG®.
    Doucet BM; Blanchard M; Bienvenu F
    Am J Occup Ther; 2021 Nov; 75(6):. PubMed ID: 34817592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Lee Silverman Voice Treatment (LSVT)® BIG on motor symptoms in a patient with severe Parkinson's disease: a case report.
    Hirakawa Y; Takeda K; Koyama S; Naoi Y; Matsushita T; Nagai T; Motoya I; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Tanabe S
    Physiother Theory Pract; 2022 Nov; 38(13):3159-3168. PubMed ID: 34125001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Voice Treatment (Lee Silverman Voice Treatment [LSVT LOUD]) for Children With Down Syndrome: Phase I Outcomes.
    Boliek CA; Halpern A; Hernandez K; Fox CM; Ramig L
    J Speech Lang Hear Res; 2022 Apr; 65(4):1228-1262. PubMed ID: 35230877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
    Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
    Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lee Silverman Voice Treatment to Improve Speech in Parkinson's Disease: A Systemic Review and Meta-Analysis.
    Pu T; Huang M; Kong X; Wang M; Chen X; Feng X; Wei C; Weng X; Xu F
    Parkinsons Dis; 2021; 2021():3366870. PubMed ID: 35070257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.